Sally Spendiff

1.0k total citations
35 papers, 711 citations indexed

About

Sally Spendiff is a scholar working on Molecular Biology, Neurology and Cell Biology. According to data from OpenAlex, Sally Spendiff has authored 35 papers receiving a total of 711 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 14 papers in Neurology and 10 papers in Cell Biology. Recurrent topics in Sally Spendiff's work include Myasthenia Gravis and Thymoma (12 papers), Mitochondrial Function and Pathology (7 papers) and Muscle Physiology and Disorders (7 papers). Sally Spendiff is often cited by papers focused on Myasthenia Gravis and Thymoma (12 papers), Mitochondrial Function and Pathology (7 papers) and Muscle Physiology and Disorders (7 papers). Sally Spendiff collaborates with scholars based in Canada, Germany and United Kingdom. Sally Spendiff's co-authors include Hanns Lochmüller, Russell T. Hepple, Tanja Taivassalo, José A. Morais, Madhusudanarao Vuda, Rita Horváth, Andreas Roos, Sudhakar Aare, Stefan Hettwer and Grace McMacken and has published in prestigious journals such as Nature Communications, Journal of Neuroscience and The Journal of Physiology.

In The Last Decade

Sally Spendiff

32 papers receiving 705 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sally Spendiff Canada 16 389 217 127 117 109 35 711
Daniela L. Rebolledo Chile 14 436 1.1× 167 0.8× 104 0.8× 66 0.6× 86 0.8× 20 699
Takahiro Jimi Japan 16 583 1.5× 184 0.8× 91 0.7× 65 0.6× 63 0.6× 52 695
Kamil Topalkara Türkiye 9 344 0.9× 91 0.4× 55 0.4× 167 1.4× 107 1.0× 14 925
Lan Wei‐LaPierre United States 12 599 1.5× 207 1.0× 57 0.4× 44 0.4× 174 1.6× 19 760
Chalonda R. Handy United States 9 638 1.6× 195 0.9× 112 0.9× 133 1.1× 127 1.2× 11 921
Seiji Shibuya Japan 18 807 2.1× 247 1.1× 123 1.0× 65 0.6× 75 0.7× 56 889
Eirini Vagena United States 10 229 0.6× 176 0.8× 47 0.4× 102 0.9× 173 1.6× 16 851
Fennigje M. Purves-Smith Canada 7 470 1.2× 328 1.5× 95 0.7× 23 0.2× 64 0.6× 7 653
Jiangping Pan United States 18 469 1.2× 156 0.7× 122 1.0× 18 0.2× 103 0.9× 29 809
Jean‐Marc Renaud Canada 15 534 1.4× 199 0.9× 120 0.9× 19 0.2× 99 0.9× 19 857

Countries citing papers authored by Sally Spendiff

Since Specialization
Citations

This map shows the geographic impact of Sally Spendiff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sally Spendiff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sally Spendiff more than expected).

Fields of papers citing papers by Sally Spendiff

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sally Spendiff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sally Spendiff. The network helps show where Sally Spendiff may publish in the future.

Co-authorship network of co-authors of Sally Spendiff

This figure shows the co-authorship network connecting the top 25 collaborators of Sally Spendiff. A scholar is included among the top collaborators of Sally Spendiff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sally Spendiff. Sally Spendiff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ubaida‐Mohien, Ceereena, Ruin Moaddel, Sally Spendiff, et al.. (2025). Serum Proteomic and Metabolomic Signatures of High Versus Low Physical Function in Octogenarians. Aging Cell. 24(5). e70002–e70002.
2.
Spendiff, Sally, Hanns Lochmüller, & Ricardo A. Maselli. (2025). Congenital myasthenic syndromes. International review of neurobiology. 182. 253–274.
3.
4.
5.
Rigau, Maria, Mattia Bosio, Emily O’Connor, et al.. (2024). Rare disease research workflow using multilayer networks elucidates the molecular determinants of severity in Congenital Myasthenic Syndromes. Nature Communications. 15(1). 1227–1227. 12 indexed citations
6.
O’Connor, Emily, Alicia DiBattista, Sally Spendiff, et al.. (2024). Development of a riboflavin-responsive model of riboflavin transporter deficiency in zebrafish. Human Molecular Genetics. 34(3). 265–276. 1 indexed citations
7.
Polavarapu, Kiran, Rachel Thompson, Sally Spendiff, et al.. (2024). Partial loss of desmin expression due to a leaky splice site variant in the human DES gene is associated with neuromuscular transmission defects. Neuromuscular Disorders. 39. 10–18. 1 indexed citations
8.
Thompson, Rachel, et al.. (2024). Estimating the Prevalence of GNE Myopathy Using Population Genetic Databases. Human Mutation. 2024(1). 7377504–7377504. 1 indexed citations
9.
Spendiff, Sally, et al.. (2023). Mitochondrial Mutations Can Alter Neuromuscular Transmission in Congenital Myasthenic Syndrome and Mitochondrial Disease. International Journal of Molecular Sciences. 24(10). 8505–8505. 8 indexed citations
10.
Pugliese, Alessia, et al.. (2023). Presynaptic Congenital Myasthenic Syndromes: Understanding Clinical Phenotypes through In vivo Models. Journal of Neuromuscular Diseases. 10(5). 731–759. 7 indexed citations
11.
Ubaida‐Mohien, Ceereena, Sally Spendiff, Alexey E. Lyashkov, et al.. (2022). Unbiased proteomics, histochemistry, and mitochondrial DNA copy number reveal better mitochondrial health in muscle of high-functioning octogenarians. eLife. 11. 17 indexed citations
12.
Spendiff, Sally, Yin Yao Dong, Lorenzo Maggi, et al.. (2022). 260th ENMC International Workshop: Congenital myasthenic syndromes 11-13 March 2022, Hoofddorp, The Netherlands. Neuromuscular Disorders. 33(9). 111–118. 5 indexed citations
13.
Manta, Alexander, Sally Spendiff, Hanns Lochmüller, & Rachel Thompson. (2021). Targeted Therapies for Metabolic Myopathies Related to Glycogen Storage and Lipid Metabolism: a Systematic Review and Steps Towards a ‘Treatabolome’. Journal of Neuromuscular Diseases. 8(3). 401–417. 3 indexed citations
14.
Morais, José A., et al.. (2019). Fidelity of muscle fibre reinnervation modulates ageing muscle impact in elderly women. The Journal of Physiology. 597(19). 5009–5023. 62 indexed citations
15.
Spendiff, Sally, et al.. (2019). Reduced Mitochondrial Content, Elevated Reactive Oxygen Species, and Modulation by Denervation in Skeletal Muscle of Prefrail or Frail Elderly Women. The Journals of Gerontology Series A. 74(12). 1887–1895. 28 indexed citations
16.
Spendiff, Sally, et al.. (2018). Influence of nerve cuff channel count and implantation site on the separability of afferent ENG. Journal of Neural Engineering. 15(4). 46004–46004. 20 indexed citations
17.
Cox, Dan, Silvia Cipriani, Sally Spendiff, et al.. (2018). SIL1 deficiency causes degenerative changes of peripheral nerves and neuromuscular junctions in fish, mice and human. Neurobiology of Disease. 124. 218–229. 10 indexed citations
18.
Aare, Sudhakar, Sally Spendiff, Madhusudanarao Vuda, et al.. (2016). Failed reinnervation in aging skeletal muscle. Skeletal Muscle. 6(1). 29–29. 79 indexed citations
19.
Gouspillou, Gilles, Celena Scheede‐Bergdahl, Sally Spendiff, et al.. (2015). Anthracycline-containing chemotherapy causes long-term impairment of mitochondrial respiration and increased reactive oxygen species release in skeletal muscle. Scientific Reports. 5(1). 8717–8717. 60 indexed citations
20.
Spendiff, Sally, Mojgan Reza, Julie L. Murphy, et al.. (2013). Mitochondrial DNA deletions in muscle satellite cells: implications for therapies. Human Molecular Genetics. 22(23). 4739–4747. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daniela L. Rebolledo Breakdown of academic impact, for papers by Takahiro Jimi Breakdown of academic impact, for papers by Kamil Topalkara Breakdown of academic impact, for papers by Lan Wei‐LaPierre Breakdown of academic impact, for papers by Chalonda R. Handy Breakdown of academic impact, for papers by Seiji Shibuya Breakdown of academic impact, for papers by Eirini Vagena Breakdown of academic impact, for papers by Fennigje M. Purves-Smith Breakdown of academic impact, for papers by Jiangping Pan Breakdown of academic impact, for papers by Jean‐Marc Renaud
Rankless by CCL
2026